Columbia Technology Ventures (CTV), the technology transfer office of Columbia University, manages close to 400 new inventions each year by researchers at NYP/Columbia. These yield over 100 licenses and over a dozen new startup companies each year.
These innovations are funded through programs including the SBIR/STTR program, the Columbia-Coulter Translational Partnership, and others. Read more about Technology Development at NYP/Columbia here and find videos about research projects at CTV here.
The National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Program and the Small Business Technology Transfer (STTR) Program provides significant funding for research by small, high-technology businesses. These programs support projects that translate clinical observations into technology that will benefit patients locally, nationally, and globally. SBIR/STTR grants usually range between $100,000 and $200,000 per year for phase I. Phase II awards provide a total of up to $750,000 over two years.
Examples of recent NIH SBIR/STTR funded projects in the Department of Surgery include Shanta Modak, PhD, infection-resistant coatings and hand disinfectants.
Columbia-Coulter Translational Partnership
The Wallace H. Coulter Foundation Translational Research Program is designed to benefit humanity by helping to translate academic innovations into practical use in order to address unmet needs in healthcare. Columbia is one of the select U.S. institutions funded by this prestigious foundation for biomedical innovation projects aimed at improving clinical practice and patient care.
The Columbia-Coulter partnership includes collaboration among the Department of Biomedical Engineering at the Fu Foundation School of Engineering and Applied Science, the Departments of Surgery, Orthopaedic Surgery and Radiology at Columbia University Medical Center, and Columbia Technology Ventures, the technology transfer office of Columbia University. The partnership provides guidance and $5 million in funding over five years (two thirds from the foundation, and one third from Columbia) to advance promising biomedical technology ideas from conception to proof-of-concept. The end-goal is to pair these ideas with a commercial entity that will invest the necessary resources to bring the concept to market.
Now in its third year at NYP/Columbia, the Columbia-Coulter partnership most recently awarded over $1 million to seven projects in March, 2015. Those including faculty in the Department of Surgery include: